Solid Organ Transplants in HIV-Infected Patients

被引:0
作者
Jack Harbell
Norah A. Terrault
Peter Stock
机构
[1] University of California San Francisco,Department of Surgery
[2] University of California San Francisco,Department of Medicine
[3] University of California San Francisco,Division of Gastroenterology
[4] University of California San Francisco,Department of Surgery
来源
Current HIV/AIDS Reports | 2013年 / 10卷
关键词
Liver transplantation; Kidney transplantation; HIV; AIDS; Liver failure; Renal failure; Hepatitis B; Hepatitis C; Immune suppression; Opportunistic infection; Graft survival; Patient survival; Selection criteria; Antiretroviral therapy; CD4+ T-cell count;
D O I
暂无
中图分类号
学科分类号
摘要
There is a growing need for kidney and liver transplants in persons living with HIV. Fortunately, with the significant advances in antiretroviral therapy and management of opportunistic infections, HIV infection is no longer an absolute contraindication for solid organ transplantation. Data from several large prospective multi-center cohort studies have shown that solid organ transplantation in carefully selected HIV-infected individuals is safe. However, significant challenges have been identified including prevention of acute rejection, management of drug-drug interactions and treatment of recurrent viral hepatitis. This article reviews the selection criteria, outcomes, and special management considerations for HIV-infected patients undergoing liver or kidney transplantation.
引用
收藏
页码:217 / 225
页数:8
相关论文
共 192 条
[1]  
Spital A(1998)Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers Transplantation 65 1187-91
[2]  
Palella FJ(1998)Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 853-60
[3]  
Delaney KM(1996)Changing the natural history of HIV disease Lancet 348 239-46
[4]  
Moorman AC(2000)Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy Clin Infect Dis 30 S5-14
[5]  
Feinberg MB(1997)Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value J Hepatol 27 18-24
[6]  
Kaplan JE(1999)Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival Clin Infect Dis 29 150-4
[7]  
Hanson D(1997)Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis J Hepatol 26 1-5
[8]  
Dworkin MS(2002)Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999 J Acquir Immune Defic Syndr 29 378-87
[9]  
Ockenga J(2003)the United States Renal Data System Am J Kidney Dis 42 1-230
[10]  
Tillmann HL(2000)Infection of mesangial cells with HIV and SIV: identification of GPR1 as a coreceptor Kidney Int 58 607-17